Arrowhead Research Corp. (ARWR) Reports In-Line Q3 EPS, Provides Update on ARC-520
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Arrowhead Research (ARWR) Sees Early Upside
August 14, 2014 9:44 AM EDTArrowhead Research (NASDAQ: ARWR) seeing strong morning upside on solid volume. Shares are up 7%.
Deutsche Bank Maintains Buy Rating on Arrowhead Research (ARWR)
August 13, 2014 9:58 AM EDTDeutsche Bank maintained a Buy rating on Arrowhead Research (NASDAQ: ARWR) with a price target of $45. Comments follow its ARC-520 update.
Analyst Alethia Young said, "We feel more confident in ARC-520 and their platform technology after this interim update. Safety looks solid... More
Arrowhead Research (ARWR) Bullish Stance Reiterated at Jefferies as ARC-520 Shows Highly Encouraging Efficacy
August 13, 2014 6:52 AM EDTJefferies analyst Thomas Wei reiterated a Buy rating and $30 price target on Arrowhead Research (NASDAQ: ARWR) as ARC-520 shows highly encouraging efficacy.
Wei commented, "ARWR provided an update from its Phase 2a trial, in which patients receiving a single dose of ARC-520... More
